|
MechanismNLRP3 inhibitors |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismLPAR1 antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismGPCR antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Viva Star Biosciences (Suzhou) Co., Ltd.
0 Patents (Medical) associated with Viva Star Biosciences (Suzhou) Co., Ltd.
100 Deals associated with Viva Star Biosciences (Suzhou) Co., Ltd.
100 Translational Medicine associated with Viva Star Biosciences (Suzhou) Co., Ltd.